[
  {
    "ts": "2026-01-12T12:00:00+00:00",
    "headline": "Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation",
    "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused on the development and commercialization of innovative solutions to treat bladder dysfunction. The company's eCoin® System is an implantable tibial nerve stimulation (ITNS) device for the treatment of urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB).",
    "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000004.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "877b4a69-a62d-3810-9c96-bbf2792a2650",
      "content": {
        "id": "877b4a69-a62d-3810-9c96-bbf2792a2650",
        "contentType": "STORY",
        "title": "Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation",
        "description": "",
        "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused on the development and commercialization of innovative solutions to treat bladder dysfunction. The company's eCoin® System is an implantable tibial nerve stimulation (ITNS) device for the treatment of urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB).",
        "pubDate": "2026-01-12T12:00:00Z",
        "displayTime": "2026-01-12T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/e1efff8c1827a2416164ff633f6854d6",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tEzXUzk4uQBJUN9VCLa3LQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/e1efff8c1827a2416164ff633f6854d6.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iuWNFOM6Te.RxBERx3Cnpw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/e1efff8c1827a2416164ff633f6854d6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000004.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000004.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:00:00+00:00",
    "headline": "Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones",
    "summary": "Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a corporate update and outlined upcoming development milestones for NXT-41x, its next-generation antibiotic-eluting biomatrix program in plastic and reconstructive surgery. NXT-41x is El",
    "url": "https://finance.yahoo.com/news/elutia-reports-preliminary-fourth-quarter-130000380.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d3982c7c-be03-3be5-9077-be21ba51e1fe",
      "content": {
        "id": "d3982c7c-be03-3be5-9077-be21ba51e1fe",
        "contentType": "STORY",
        "title": "Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones",
        "description": "",
        "summary": "Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a corporate update and outlined upcoming development milestones for NXT-41x, its next-generation antibiotic-eluting biomatrix program in plastic and reconstructive surgery. NXT-41x is El",
        "pubDate": "2026-01-12T13:00:00Z",
        "displayTime": "2026-01-12T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/acb8ce730ecd9f3870468a11e1c1300d",
          "originalWidth": 2048,
          "originalHeight": 455,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UZDWpsnvZMiblfXugK_fkw--~B/aD00NTU7dz0yMDQ4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/acb8ce730ecd9f3870468a11e1c1300d.cf.webp",
              "width": 2048,
              "height": 455,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vHtfmG3ERYsDP0feqscEWg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/acb8ce730ecd9f3870468a11e1c1300d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/elutia-reports-preliminary-fourth-quarter-130000380.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/elutia-reports-preliminary-fourth-quarter-130000380.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELUT"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:09:00+00:00",
    "headline": "Illumina's New Connected Multiomics Platform Set to Boost Its Stock",
    "summary": "ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.",
    "url": "https://finance.yahoo.com/news/illuminas-connected-multiomics-platform-set-130900387.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "81a52fe0-36f6-3b60-923f-4e7ef4d2a600",
      "content": {
        "id": "81a52fe0-36f6-3b60-923f-4e7ef4d2a600",
        "contentType": "STORY",
        "title": "Illumina's New Connected Multiomics Platform Set to Boost Its Stock",
        "description": "",
        "summary": "ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.",
        "pubDate": "2026-01-12T13:09:00Z",
        "displayTime": "2026-01-12T13:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/illuminas-connected-multiomics-platform-set-130900387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/illuminas-connected-multiomics-platform-set-130900387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ILMN"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "STE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:56:00+00:00",
    "headline": "GeneDx Partners With Komodo Health to Advance Rare Disease Research",
    "summary": "WGS collaborates with Komodo Health to link genomic data with real-world insights, expanding data monetization and strengthening its role in rare disease research.",
    "url": "https://finance.yahoo.com/news/genedx-partners-komodo-health-advance-145600850.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d36e1f73-dd98-348b-951a-dced27ad2c60",
      "content": {
        "id": "d36e1f73-dd98-348b-951a-dced27ad2c60",
        "contentType": "STORY",
        "title": "GeneDx Partners With Komodo Health to Advance Rare Disease Research",
        "description": "",
        "summary": "WGS collaborates with Komodo Health to link genomic data with real-world insights, expanding data monetization and strengthening its role in rare disease research.",
        "pubDate": "2026-01-12T14:56:00Z",
        "displayTime": "2026-01-12T14:56:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/genedx-partners-komodo-health-advance-145600850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/genedx-partners-komodo-health-advance-145600850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WGS"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:23:18+00:00",
    "headline": "Boston Scientific to buy incontinence device maker Valencia",
    "summary": "The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.",
    "url": "https://www.medtechdive.com/news/Boston-Scientific-acquires-Valencia-urinary-incontinence/809397/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "668641ac-dba8-3493-9bca-dd8431d6fec6",
      "content": {
        "id": "668641ac-dba8-3493-9bca-dd8431d6fec6",
        "contentType": "STORY",
        "title": "Boston Scientific to buy incontinence device maker Valencia",
        "description": "",
        "summary": "The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.",
        "pubDate": "2026-01-12T14:23:18Z",
        "displayTime": "2026-01-12T14:23:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/6f2c921e458c0bdbec82a4e6b2e150ce",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Boston Scientific's headquarters is in Marlborough, Massachusetts.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SydpRG0OUlg3arn0g7lt2w--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/6f2c921e458c0bdbec82a4e6b2e150ce.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6kZkJqYDm1YnQIfTxYuyLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/6f2c921e458c0bdbec82a4e6b2e150ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/Boston-Scientific-acquires-Valencia-urinary-incontinence/809397/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-buy-incontinence-device-142318665.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T23:00:04+00:00",
    "headline": "Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note",
    "summary": "Boston Scientific (BSX) reached $95.72 at the closing of the latest trading day, reflecting a -1.97% change compared to its last close.",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-stock-drops-230004497.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "34506e27-c6fb-3bfb-afee-9896d1b492e4",
      "content": {
        "id": "34506e27-c6fb-3bfb-afee-9896d1b492e4",
        "contentType": "STORY",
        "title": "Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note",
        "description": "",
        "summary": "Boston Scientific (BSX) reached $95.72 at the closing of the latest trading day, reflecting a -1.97% change compared to its last close.",
        "pubDate": "2026-01-12T23:00:04Z",
        "displayTime": "2026-01-12T23:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vqy2StQrekYiw3wwFUCZ6A--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N1J8mAJyPZolYBef44MAwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-stock-drops-230004497.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-stock-drops-230004497.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]